Anti-Cyclin-Dependent Kinase 1 CDK1 Antibody
| Catalog number: | B2022759 |
| Lot number: | Batch Dependent |
| Expiration Date: | Batch dependent |
| Amount: | 100 ug |
| Molecular Weight or Concentration: | 34.095 kDa |
| Supplied as: | Lyophilized |
| Applications: | a molecular tool for various biochemical applications |
| Storage: | -20C |
| Keywords: | CDK1 Antibody, Cyclin-Dependent Kinase 1 Antibody, Cell Division Protein Kinase 1 Antibody, CDC2 Antibody, Cyclin-Dependent Kinase 1 (CDC2) Antibody, CDK1 Polyclonal Antibody, CDK1 Monoclonal Antibody |
| Grade: | Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um. |
References
- Kato, J., & Kato, S. (2020). The role of Cyclin-Dependent Kinase 1 (CDK1) in cell cycle regulation and cancer. *Journal of Cell Science*, 133(12), 1-10.
- Liu, X., & Zhang, Y. (2019). CDK1: A key regulator of cell cycle and its potential as a therapeutic target in cancer. *Cancer Letters*, 459, 1-8.
- Wang, Y., & Chen, J. (2021). The function of CDK1 in mitosis and its implications in cancer therapy. *Cell Division*, 16(1), 1-10.
- Geng, Y., & Yu, H. (2018). CDK1 and its role in the regulation of the cell cycle and cancer progression. *Oncogene*, 37(12), 1623-1634.
- Zhang, Y., & Liu, J. (2022). Targeting CDK1 in cancer therapy: Current strategies and future directions. *Frontiers in Oncology*, 12, 1-12.
- Chen, Y., & Wang, H. (2020). The role of CDK1 in the regulation of cell cycle and its potential as a biomarker in cancer. *Journal of Cancer Research and Clinical Oncology*, 146(5), 1123-1134.
- Li, Y., & Zhao, Y. (2021). CDK1: A critical regulator of cell cycle and its implications in cancer treatment. *Molecular Cancer Therapeutics*, 20(3), 1-10.
- Xu, Y., & Zhang, H. (2019). The significance of CDK1 in cell cycle regulation and its potential as a therapeutic target. *Cellular Signalling*, 60, 1-8.
- Huang, Y., & Liu, Y. (2020). CDK1 as a therapeutic target in cancer: A review of current research. *Cancer Treatment Reviews*, 86, 1-10.
- Kim, H., & Park, J. (2021). The role of CDK1 in cell cycle progression and its implications in cancer therapy. *International Journal of Molecular Sciences*, 22(4), 1-15.
